International Journal of Clinical Research

Objective: To explore the clinical effect of using modified Banxia Baizhu Tianma Tang combined with butylphthalide in the treatment of acute cerebral infarction patients with wind phlegm stasis type. Method: 88 patients with acute cerebral infarction of wind phlegm stasis type admitted to our hospital from October 2022 to October 2023 were selected. They were divided into a control group (treated with butylphthalide) and an observation group (treated with Banxia Baizhu Tianma Tang) according to the treatment method, with 44 cases in each group. The treatment effects of the two groups were compared. Result: There was no statistically significant difference in hemorheological indicators and traditional Chinese medicine syndrome score between the two groups of patients before treatment (P>0.05). After intervention, the hemorheological indicators of the observation group were better than those of the control group, and the traditional Chinese medicine syndrome score was lower than that of the control group, with statistical significance (P<0.05). Conclusion: The use of modified Banxia Baizhu Tianma Tang combined with butylphthalide in the treatment of acute cerebral infarction patients with wind phlegm stasis type in clinical practice can significantly improve the patients blood rheology, alleviate clinical symptoms, promote rehabilitation, and has high application value.

Banxia Baizhu Tianma Tang; Butylphthalein; Wind phlegm stasis type; Acute cerebral infarction